DRI vs FDMT · P/E 22, rev $12.08B vs rev $37.0K
Darden Restaurants Inc (DRI) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
Darden Restaurants Inc (DRI) is a restaurants company listed on NYSE.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported DRI revenue for 2025-05-25 was $12.08B. Net income was $1.05B. Revenue was up 6.0% from 2024-05-26 to 2025-05-25. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
DRI currently screens at market cap $24.20B and trailing P/E 22.3. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the DRI and FDMT stock pages for the full models.
Not investment advice.